Oneto v. Watson

District Court, N.D. California·Decided November 18, 2022·No. 3:22-cv-05206·Unknown

Opinion

ROY J ONETO, Case No. 3:22-cv-05206-WHO

Plaintiff, ORDER DENYING MOTION TO v. REMAND

MELVIN WATSON, et al., Re: Dkt. No. 10 Defendants.

Plaintiff Roy Oneto filed this underlying action in state court, asserting several claims against his insurance providers for failing to cover a medical operation. One named defendant, Melvin Watson, removed the case to federal court. Oneto filed a motion to remand, asserting that the removal was improper for various reasons but not contesting jurisdiction. None of the reasons has merit, and his motion is denied. Oneto’s initial complaint was filed on December 9, 2021, against Cigna Health and Life Insurance Company, Cigna Health Management Inc., Melvin Watson, M.D., and Does 1 through 100. See Notice of Removal (“Rem.”) [Dkt. No. 1] Ex. A. Oneto sent Scott Klausner, attorney for the Cigna entities, a courtesy copy of the complaint on December 10, 2021. See Motion to Remand (“Mot.”) [Dkt. No. 10] Ex. 1. Oneto served Cigna Health and Life Insurance Company and Cigna Health Management Inc. on February 2, 2022. Rem. Exs. C, D. On March 21, 2022, Klausner said in an email to Oneto’s counsel, “I have concerns about the claims asserted against Dr. Watson individually.” Mot. Ex. 3. In a separate email that day he acknowledged his firm represented the Cigna entities and said, “I imagine we will also represent Dr. Watson, but I don’t have that confirmed yet. . . . I’ll have to await confirmation regarding our Oneto’s counsel that he was “still waiting on word” with respect to whether his firm would represent Watson. Opposition to Remand (“Oppo.”) [Dkt. No. 12] Ex. 1. On April 25, 2022, Oneto served Klausner via an amended complaint, substituting in Cigna Healthcare of Texas, Inc. (“Cigna Texas”), and “Melvin Watson in his capacity as Cigna Healthcare of Texas Vice President and Medical Director.” Mot. Ex. 4-5. The following day, Klausner sent an email to Oneto’s counsel saying, “I don’t understand the substitution of Dr. Watson for Doe 31. Dr. Watson was named as a defendant in the original complaint, so he’s already a party.” Oppo. Ex. 1. Oneto’s attorney responded, “The amendments address your concern regarding the suit against Dr. Watson as an ‘individual.’” Id. Klausner replied, “I’m not sure I follow. It seems to me that you’ve now sued the same defendant twice,” and then: “In any event, it looks like Dr. Watson may have separate counsel and will not be represented by [Klausner’s firm] Cole Pedroza. I’ll confirm shortly once a final decision is made.” Id. Klausner informed Oneto’s counsel via email on May 3, 2022, that Watson would have alternative representation. Oppo. Ex. 1. On August 4, 2022, Cigna Texas was served. Mot. Ex. 6. And on August 13, 2022, “Melvin Watson, MD., VP-Medical Director for Cigna Healthcare of Texas, Inc.” was served with the summons, complaint, exhibits, amended complaint, notice of remot appearance, and notice of intent to sue. Mot. Ex. 7 at Crisp Ex. 2; see also Mot. Ex. 7 ¶¶ 4-5 (stating Watson was served “as the ‘Agent for service of process’ on behalf of Melvin Watson, MD., VP-Medical Director for Cigna Healthcare of Texas, Inc.”). On September 8, 2022, Watson filed an answer in state court, see Mot. 4:3-7, and four days later removed the case to federal court. See Rem. On October 10, 2022, Oneto filed this motion to remand, see Mot. Under Civil Local Rule 7-1(b), I found this matter appropriate for resolution without oral argument and vacated the hearing scheduled for November 21, 2022. See Dkt. No. 14. Generally, a case can only be removed from state to federal court when the federal court federal diversity jurisdiction exists when each plaintiff is a citizen of a different state from each defendant and the amount in controversy exceeds $75,000. Natural persons are the citizens of the state in which they are domiciled—that is, the state in which they reside with intent to remain permanently. See Kanter v. Warner-Lambert Co., 265 F.3d 853, 857 (9th Cir. 2001). “[R]emoval statutes should be construed narrowly in favor of remand to protect the jurisdiction of state courts.” Cnty. of San Mateo v. Chevron Corp., 32 F.4th 733, 764 (9th Cir. 2022) (quoting Harris v. Bankers Life and Cas. Co., 425 F.3d 689, 698 (9th Cir. 2005)). “The defendant has the burden of proving by a preponderance of the evidence that the requirements for removal jurisdiction have been met.” Id. at 746 (citing Leite v. Crane Co., 749 F.3d 1117, 1122 (9th Cir. 2014)). Removability is “generally determined as of the time of the petition for removal.” Local Union 598, Plumbers & Pipefitters Indus. Journeymen & Apprentices Training Fund v. J.A. Jones Constr. Co., 846 F.2d 1213, 1215 (9th Cir. 1988). As relevant here, 28 U.S.C. § 1446(b)(1) provides that a “notice of removal of a civil action or proceeding shall be filed . . . within 30 days after the service of summons upon the defendant.” As a preliminary matter, Oneto does not contest that I have diversity jurisdiction over this case, given that the amount in controversy is over $75,000 and he is a citizen of California while Watson is a citizen of Georgia, Cigna Texas is a citizen of Texas, and the other two Cigna entities are citizens of Connecticut. See Rem. ¶ 7; 28 U.S.C. § 1332(a). Rather, he asserts that removal was improper for three reasons. None is convincing. I address each in turn. I. Diversity Based on the Face of the Complaint Oneto first argues that the case was improperly removed to federal court because no facts “on the face of the complaint” support diversity jurisdiction since there are no facts showing Watson’s domicile. Mot. 4:14-6:13. This argument lacks merit. As the defendants point out, Oneto selectively cites portions of Harris v. Bankers Life and Casualty Company, 425 F.3d 689 (9th Cir. 2005), as support for his argument. The Ninth Circuit service of the complaint if the facts of diversity are not clear on the face of the complaint. Id. at 694-96. In other words, Harris stands for the proposition that the thirty-day period for removal does not begin to run unless the basis of diversity citizenship is clear on the face of the complaint, but it does not preclude a defendant from removing the complaint based on additional investigation to confirm the basis for removal. This interpretation was confirmed by the Ninth Circuit in Roth v. Hollywood Medical Center, L.P., which explained: Harris did not address a case in which a defendant conducted its own investigation, even though not required to do so, and discovered that a case was removable. We conclude that [28 U.S.C.] §§ 1441 and 1446, read together, permit a defendant to remove outside the two thirty-day periods on the basis of its own information, provided that it has not run afoul of either of the thirty-day deadlines. . . . [A plaintiff should not] be able to prevent or delay removal by failing to reveal information showing removability and then objecting to removal when the defendant has discovered that information on its own. Similarly, a plaintiff’s ignorance of the citizenship of [defendants] should not defeat removal if defendant independently knows or learns that information.

Oneto v. Watson, (N.D. Cal. 2022).

Oneto v. Watson (Oneto v. Watson) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Shanna Kuxhausen v. Bmw Financial Services Na Llc
707 F.3d 1136 (Ninth Circuit, 2013)
Amy Roth v. Cha Hollywood Medical Center
720 F.3d 1121 (Ninth Circuit, 2013)
Douglas Leite v. Crane Company
749 F.3d 1117 (Ninth Circuit, 2014)
County of San Mateo v. Chevron Corp.
32 F.4th 733 (Ninth Circuit, 2022)